Suchergebnisse - "Ogawa, Chikara"

PubPharm (209)

1

Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab

enthalten in: Targeted oncology | 2024

von Persano, M. | Rimini, M. | Tada, T. | +72

2

Kinetics of the hepatitis B core-related antigen and treatment responses in chronic hepatitis B patients treated with tenofovir alafenamide

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2024

von Itokawa, N. | Atsukawa, M. | Tsubota, A. | +21

3

Effect of treatment periods on efficacy of glecaprevir and pibrentasvir in chronic hepatitis C : A nationwide, prospective, multicenter study

enthalten in: JGH open : an open access journal of gastroenterology and hepatology | 2024

von Morita, A. | Tamaki, N. | Kobashi, H. | +26

4

Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Rimini, M. | Stefanini, B. | Tada, T. | +75

5

Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma

enthalten in: Cancer reports (Hoboken, N.J.) | 2024

von Ohama, H. | Hiraoka, A. | Tada, T. | +42

6

Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older : Multicenter study

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2024

von Hatanaka, T. | Kakizaki, S. | Hiraoka, A. | +45

7

A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma : TACTICS-L Trial

enthalten in: Liver cancer | 2024

von Kudo, M. | Ueshima, K. | Saeki, I. | +23

8

Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate-stage hepatocellular carcinoma

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Tada, T. | Kumada, T. | Hiraoka, A. | +42

9

α-FAtE : A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma

enthalten in: International journal of cancer | 2024

von Rossari, F. | Tada, T. | Suda, G. | +70

10

Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma

enthalten in: Targeted oncology | 2024

von Camera, S. | Rimini, M. | Rossari, F. | +73

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]